Activated T-cell and bispecific antibody immunotherapy for high-risk breast cancer. Bench to bedside. [electronic resource]
Producer: 20010906Description: 130-6 p. digitalISSN:- 0001-5792
- Antibodies, Bispecific -- therapeutic use
- Antigens, Neoplasm -- immunology
- Breast Neoplasms -- therapy
- CD3 Complex -- immunology
- Cytokines -- metabolism
- Cytotoxicity, Immunologic
- Drug Therapy, Combination
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor -- administration & dosage
- Humans
- Immunotherapy -- methods
- Immunotherapy, Adoptive -- methods
- Interleukin-2 -- administration & dosage
- Lymphocyte Activation -- immunology
- Receptor, ErbB-2 -- immunology
- T-Lymphocytes -- immunology
- T-Lymphocytes, Cytotoxic -- metabolism
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.